Joint Deformities #rheumatoid #arthritis, #ra, #joint #deformities, #joint #deformity #treatments, #advanced #rheumatoid #arthritis #treatment, #arthritis, #bone #deformities, #pannus, #rheumatoid #factor, #joint #damage, #finger #deformities, #arthritis #today #magazine #

Posted On Sep 17 2017 by

# Joint Deformities in Rheumatoid Arthritis Thanks to earlier diagnosis and more effective treatments, joint deformities in people with rheumatoid arthritis (RA) are becoming less frequent and severe. What Causes Joint Deformities in RA? In a joint affected by RA, inflammatory cells of the immune system gather in the lining of the joint (called synovium), forming a fibrous layer of abnormal tissue (called pannus). The pannus releases substances that quicken bone erosion, cartilage destruction and damage to the surrounding ligaments. The involved joints lose their shape and alignment, resulting in deformities. Severe deformities lead to loss of joint function and …


Pharma magazine #top #10 #pharma #companies

Posted On Sep 9 2017 by

#pharma magazine # PharmaTimes Magazine PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis. PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What’s more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners. Click to subscribe to PharmaTimes in paper or print, or to sign up for our …


Pharmaceutical Commerce Magazine #lupin #pharma

Posted On Aug 19 2017 by

#pharma magazine # Main menu A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy Walgreens, founded in 1901, is now one of the leading drugstore chains in the US, Orphan drug commercialization is maturing Despite their moniker, rare diseases are anything but rare when taken in the aggregate. By definition, a rare disease, often genetic in nature, is chronic, life-threatening and impacts fewer than 200,000 people in the US, or five per 10,000 in Value frameworks are here: What to do about them? Over the last 20 years, new health care innovations have had a dramatic effect on patient longevity and …


Forbes India Magazine – Ajanta Pharma: The small big dream #asia #pharma

Posted On Aug 10 2017 by

#ajanta pharma products # Ajanta Pharma: The small big dream Rajesh Agrawal (left), Ajanta Pharma’s joint managing director, with brother Yogesh, who is also managing director of the company, at their Kandivli facility o date, yesteryear bollywood superstar Jeetendra has appeared in only one television commercial to endorse a product. That was in the 1990s, for a popular over-the-counter (OTC) energiser capsule for men called 30-Plus . Jeetendra was in his late 40s then, but looked much younger. Though 30-Plus sold like hot cakes, revenues from its sales didn t justify the exorbitant marketing cost that its maker, a then …


Pharmaceutical Commerce Magazine #orchid #pharma

Posted On Aug 4 2017 by

#pharma magazine # Main menu A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy Walgreens, founded in 1901, is now one of the leading drugstore chains in the US, Orphan drug commercialization is maturing Despite their moniker, rare diseases are anything but rare when taken in the aggregate. By definition, a rare disease, often genetic in nature, is chronic, life-threatening and impacts fewer than 200,000 people in the US, or five per 10,000 in Value frameworks are here: What to do about them? Over the last 20 years, new health care innovations have had a dramatic effect on patient longevity and …


Gamasutra: Brice Morrison s Blog – For a Career in Gaming, are Game Design Degrees Worth It? #game #development, #game #developer, #game #programming, #game #programmer, #videogame, #artificial #intelligence, #3d #animation, #game #design, #3d #modeling, #game #business, #game #jobs, #game #directory, #game #development #software, #game #technology, #3d #technology, #game #producer, #game #audio, #game #animation, #virtual #reality, #digital #entertainment, #pc #game, #xbox #game, #game #news, #new #game, #arcade #development, #nintendo #development, #playstation #development, #playstation #2, #ps2, #dreamcast #development, #game #developer #magazine, #computer #game #developers #conference, #game #developers #conference, #independent #game #developers #conference, #cmp #game #media #group, #game #industry #research, #online #game #development, #digital #assets, #free #textures, #free #3d #models, #free #shaders, #gamasutra #exchange, #3d #studio #max #textures

Posted On Aug 3 2017 by

# 11 comments The following blog post, unless otherwise noted, was written by a member of Gamasutra�s community. The thoughts and opinions expressed are those of the writer and not Gamasutra or its parent company. This blog post is reprinted from The Game Prodigy. a site for students and parents interested in careers in games. Many students and parents believe that if they are interested in a career in gaming, then the best thing for them to pursue is a degree in “Game Design”, “Game Programming”, or “Game Art and Animation”. There is no shortage of schools nowadays offering these …


Forbes India Magazine – Ajanta Pharma: The small big dream #pharma #opportunities

Posted On Jul 11 2017 by

#ajanta pharma products # Ajanta Pharma: The small big dream Rajesh Agrawal (left), Ajanta Pharma’s joint managing director, with brother Yogesh, who is also managing director of the company, at their Kandivli facility o date, yesteryear bollywood superstar Jeetendra has appeared in only one television commercial to endorse a product. That was in the 1990s, for a popular over-the-counter (OTC) energiser capsule for men called 30-Plus . Jeetendra was in his late 40s then, but looked much younger. Though 30-Plus sold like hot cakes, revenues from its sales didn t justify the exorbitant marketing cost that its maker, a then …


Forbes India Magazine – Ajanta Pharma: The small big dream #capricorn #pharma

Posted On Jun 17 2017 by

#ajanta pharma products # Ajanta Pharma: The small big dream Rajesh Agrawal (left), Ajanta Pharma’s joint managing director, with brother Yogesh, who is also managing director of the company, at their Kandivli facility o date, yesteryear bollywood superstar Jeetendra has appeared in only one television commercial to endorse a product. That was in the 1990s, for a popular over-the-counter (OTC) energiser capsule for men called 30-Plus . Jeetendra was in his late 40s then, but looked much younger. Though 30-Plus sold like hot cakes, revenues from its sales didn t justify the exorbitant marketing cost that its maker, a then …


Pharma magazine #pharma #marketing #strategies

Posted On May 18 2017 by

#pharma magazine # PharmaTimes Magazine PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis. PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What’s more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners. Click to subscribe to PharmaTimes in paper or print, or to sign up for our …


Pharma magazine #pharmaceutical #companies #news

Posted On May 2 2017 by

#pharma magazine # PharmaTimes Magazine PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis. PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What’s more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners. Click to subscribe to PharmaTimes in paper or print, or to sign up for our …